Clinical trials: Off-label Indications
- Condition Off-label Indications
- Funder type Industry (pharma, biotech, devices)
- Age group Children (under 18)
Lymphoma, Leukemia
Managed Access Programs for CTL019, Tisagenlecleucel
The purpose of this registration is to list Managed Access Programs (MAPs) related to CTL019, Tisagenlecleucel
- Conditions
- Lymphoma, Leukemia, Off-label Indications
- Trial name
- NCT03601442
- Testing
- CTL019
- Sponsor
- Novartis Pharmaceuticals